Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Eyal Epstein"'
Autor:
Hadas Tamir, Tal Noy-Porat, Sharon Melamed, Lilach Cherry-Mimran, Moria Barlev-Gross, Ron Alcalay, Yfat Yahalom-Ronen, Hagit Achdout, Boaz Politi, Noam Erez, Shay Weiss, Ronit Rosenfeld, Eyal Epstein, Ohad Mazor, Efi Makdasi, Nir Paran, Tomer Israely
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract The eradication of smallpox was officially declared by the WHO in 1980, leading to discontinuation of the vaccination campaign against the virus. Consequently, immunity against smallpox and related orthopoxviruses like Monkeypox virus gradua
Externí odkaz:
https://doaj.org/article/6a40b8cca9af49db9e076e3f3cd2d842
Autor:
Noam Cohen, Irit Simon, Ophir Hazan, Arnon Tal, Hanan Tzadok, Lilach Levin, Meni Girshengorn, Lilach Cherry Mimran, Niva Natan, Tzadok Baruhi, Alon Ben David, Osnat Rosen, Shlomo Shmaya, Sarah Borni, Noa Cohen, Edith Lupu, Adi Kedmi, Orian Zilberman, Avital Jayson, Arik Monash, Eyal Dor, Eran Diamant, Michael Goldvaser, Inbar Cohen-Gihon, Ofir Israeli, Shirley Lazar, Ohad Shifman, Adi Beth-Din, Anat Zvi, Ziv Oren, Arik Makovitzki, Elad Lerer, Avishai Mimran, Einat Toister, Ran Zichel, Yaakov Adar, Eyal Epstein
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
The COVID-19 pandemic has led to high global demand for vaccines to safeguard public health. To that end, our institute has developed a recombinant viral vector vaccine utilizing a modified vesicular stomatitis virus (VSV) construct, wherein the G pr
Externí odkaz:
https://doaj.org/article/decca5fe62ee475690287d8e70308a6f
Autor:
Einat Toister, Lilach Cherry, Edith Lupu, Arik Monash, Eyal Dor, Lilach Levin, Meni Girshengorn, Niva Natan, Shira Chapman, Shlomo Shmaya, Eyal Epstein, Yaakov Adar, Ran Zichel, Yakir Ophir, Eran Diamant
Publikováno v:
Vaccines, Vol 12, Iss 4, p 374 (2024)
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than seven million deaths worldwide. To reduce viral spread, the Israel Institute for Biological Research (IIBR) developed and produce
Externí odkaz:
https://doaj.org/article/7396402146a4420489f34910524eb755
Autor:
Tal Noy-Porat, Hadas Tamir, Ron Alcalay, Ronit Rosenfeld, Eyal Epstein, Lilach Cherry, Hagit Achdout, Noam Erez, Boaz Politi, Yfat Yahalom-Ronen, Shay Weiss, Sharon Melamed, Tomer Israely, Ohad Mazor, Nir Paran, Efi Makdasi
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 5 (2023)
ABSTRACT Members of the Orthopoxvirus genus can cause severe infections in humans. Global vaccination against smallpox, caused by the variola virus, resulted in the eradication of the disease in 1980. Shortly thereafter, vaccination was discontinued,
Externí odkaz:
https://doaj.org/article/9ae3c1ac218b462d9e1b5066a2ed8763
Autor:
Ronit Rosenfeld, Ron Alcalay, Anat Zvi, Alon Ben-David, Tal Noy-Porat, Theodor Chitlaru, Eyal Epstein, Ofir Israeli, Shirley Lazar, Noa Caspi, Ada Barnea, Eyal Dor, Inbar Chomsky, Shani Pitel, Efi Makdasi, Ran Zichel, Ohad Mazor
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Hyper-immune antisera from large mammals, in particular horses, are routinely used for life-saving anti-intoxication intervention. While highly efficient, the use of these immunotherapeutics is complicated by possible recipient reactogenicity and lim
Externí odkaz:
https://doaj.org/article/30b19251d1ca439abe77d48d5514e1c8
Autor:
Noam Cohen, Yaron Vagima, Odelia Mouhadeb, Einat Toister, Hila Gutman, Shlomi Lazar, Avital Jayson, Arbel Artzy-Schnirman, Josué Sznitman, Arie Ordentlich, Shmuel Yitzhaki, Dror Seliktar, Emanuelle Mamroud, Eyal Epstein
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Recent advances in the field of cell therapy have proposed new solutions for tissue repair and regeneration using various cell delivery approaches. Here we studied ex vivo a novel topical delivery system of encapsulated cells in hybrid polyethylene g
Externí odkaz:
https://doaj.org/article/c8b304ced3fd49f7843aefe214049d08
Autor:
Ronit Rosenfeld, Tal Noy-Porat, Adva Mechaly, Efi Makdasi, Yinon Levy, Ron Alcalay, Reut Falach, Moshe Aftalion, Eyal Epstein, David Gur, Theodor Chitlaru, Einat B. Vitner, Sharon Melamed, Boaz Politi, Ayelet Zauberman, Shirley Lazar, Adi Beth-Din, Yentl Evgy, Shmuel Yitzhaki, Shmuel C. Shapira, Tomer Israely, Ohad Mazor
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Here, using the K18-hACE2 transgenic mice model, the authors report the in vivo efficacy of a fully human neutralizing antibody against SARS-CoV-2 and show that when administered before or up to 3 days post infection, treated mice do not exhibit dise
Externí odkaz:
https://doaj.org/article/46809b3d714542f1b041f07ea3d49be0
Autor:
Tal Noy-Porat, Efi Makdasi, Ron Alcalay, Adva Mechaly, Yinon Levy, Adi Bercovich-Kinori, Ayelet Zauberman, Hadas Tamir, Yfat Yahalom-Ronen, Ma’ayan Israeli, Eyal Epstein, Hagit Achdout, Sharon Melamed, Theodor Chitlaru, Shay Weiss, Eldar Peretz, Osnat Rosen, Nir Paran, Shmuel Yitzhaki, Shmuel C. Shapira, Tomer Israely, Ohad Mazor, Ronit Rosenfeld
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-7 (2020)
Here, Noy-Porat, Makdasi et al. report the isolation of a panel of neutralizing mAbs selected against SARS-CoV-2 receptor-binding domain (RBD) from a phage display library constructed based on patient samples collected in the acute phase of the disea
Externí odkaz:
https://doaj.org/article/b2261c0965d74199a91b395d6e6b9e4c
Publikováno v:
Bio-Protocol, Vol 11, Iss 23 (2021)
The technology of cell carriers was developed as a response to the need for high cell density to enable higher production levels in cell-based production processes. To follow the production process, quantifying the number of cells on these carriers i
Externí odkaz:
https://doaj.org/article/8c11706903944caf8cb4f99c4bea164d
Autor:
Tal Noy-Porat, Adva Mechaly, Yinon Levy, Efi Makdasi, Ron Alcalay, David Gur, Moshe Aftalion, Reut Falach, Shani Leviatan Ben-Arye, Shirley Lazar, Ayelet Zauberman, Eyal Epstein, Theodor Chitlaru, Shay Weiss, Hagit Achdout, Jonathan D. Edgeworth, Raghavendra Kikkeri, Hai Yu, Xi Chen, Shmuel Yitzhaki, Shmuel C. Shapira, Vered Padler-Karavani, Ohad Mazor, Ronit Rosenfeld
Publikováno v:
iScience, Vol 24, Iss 5, Pp 102479- (2021)
Summary: Neutralizing antibodies represent a valuable therapeutic approach to countermeasure the current COVID-19 pandemic. Emergence of SARS-CoV-2 variants emphasizes the notion that antibody treatments need to rely on highly neutralizing monoclonal
Externí odkaz:
https://doaj.org/article/5be2c18d8ba44814aa7c3af9cabd005d